CR is definitely the risk and it would be particularly painful given the lengths management have gone to avoid it.Clearly they don't want to dilute and the next few months are key. If they get through there is excellent upside.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
ASX Market Open: Rising Aussie markets to ignore Wall Street's Thanksgiving caution | November 28, 2024